pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
Endpoints·Apr 23·1 min read
save

Endpoints wins Neal Awards for Trump and gene editing coverage, JPM event

Endpoints News was recognized with three 2026 Neal Awards for its coverage of the drug industry's relationship with the Trump administration, a three-part series on the future of CRISPR gene editing, and for its event ...

Apr 23, 2026·read at Endpoints ↗

Endpoints News Executive Editor Drew Armstrong, Deputy Editor Nicole Wetsman, Senior Science Correspondent Ryan Cross and Managing Director Ryan McRae April 23, 2026 08:55 AM EDT Editor's note End­points wins Neal Awards for Trump and gene edit­ing cov­er­age, JPM event Drew Armstrong Executive Editor End­points News was rec­og­nized with three 2026 Neal Awards for its cov­er­age of the drug in­dus­try’s re­la­tion­ship with the Trump ad­min­is­tra­tion, a three-part se­ries on … Sign up to read this article for free. Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox. SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER

source

Reporting by Endpoints.

read at Endpoints ↗
104 words · retrieved Apr 26
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

topics
CRISPR/Cas93

related stories

  • May 13#ASGCT26: Tessera reveals strongest data yet for in vivo sickle cell therapyEndpoints
  • May 13STAT+: Drug meant to make gene therapy safer may also make it less effectiveSTAT
  • May 13STAT+: Scientists link boy’s tumor to gene therapy viruses, in rare findingSTAT
  • May 12STAT+: Capsida says it still doesn’t know what caused gene therapy deathSTAT
  • May 11STAT+: Five years after disaster, a rare disease community gets new chance at treatmentSTAT